Donate
Myeloma Minute

Join Dr. Brian G.M. Durie as he discusses the latest news from the American Society of Hematology (ASH) Conference which recently convened in San Francisco on December 6-8th.

The ASH annual meeting is the largest global blood cancer meeting, featuring over 3,000 scientific abstracts, and was attended by more than 20,000 medical professionals.

Dr. Ola Landgren at ASH 2014 convention
Dr. Ola Landgren: Carfilzomib, lenalidomide, dexamethasone in high-risk smoldering myeloma (ASH 2014)
Read more
stethoscope and clipboard with a checklist
How to Be Safer As You Live Longer: A Patient Checklist
Read more
Previous Post
Miscellany: A recap of IMW 2015, a drug cost report from Tufts, and vacation reading that matters
Next Post
Living Well With Myeloma: NLB Members Address Key Patient and Caregiver Questions

Give Where Most Needed

Learn More

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.